01519nam a2200313Ia 4500001001200000003000800012006001900020007001500039008004100054020001500095020001800110040002100128035002100149050002500170110012300195245032200318260005600640300001400696504004100710533015200751650003700903650002200940650002700962650002700989655002901016710001701045856012601062999001701188ebr10237094CaPaEBRm        u        cr cn|||||||||080521s2008    dcu     sb    000 0 eng d  z0309118662  z9780309118668  aCaPaEBRcCaPaEBR  a(OCoLC)56804397214aRA644.I6bI56 2008eb2 aInstitute of Medicine (U.S.).bCommittee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic.10aAntivirals for pandemic influenzah[electronic resource] :bguidance on developing a distribution and dispensing program /cCommittee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.  aWashington, DC :bNational Academies Press,cc2008.  ax, 122 p.  aIncludes bibliographical references.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2009.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aAntiviral agentsxEffectiveness. 0aAntiviral agents. 0aEpidemicsxPrevention. 0aInfluenzaxPrevention. 7aElectronic books.2local2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10237094zAn electronic book accessible through the World Wide Web; click to view  c37712d37712